Purpose: Peyronie's disease is a fibromatosis resulting in scarring of the
tunica albuginea. While the inciting event is believed to be trauma to the
erect penis, little is understood about the cascade of cellular events that
leads to the formation of the plaque. Dysregulated wound healing serves as
a paradigm for the study of this condition. Previous work has demonstrated
a role for fibrogenic cytokines in wound healing, fibromatoses, including
Peyronie's disease. We analyze the expression of the fibrogenic cytokine, b
asic fibroblast growth factor (FGF), by fibroblasts derived from Peyronie's
disease tissue.
Materials and Methods: Patients with Peyronie's disease undergoing either p
enile prosthesis insertion or Nesbit penile plication surgery had biopsy sp
ecimens removed from the plaque and from normal tunical tissue remote from
the plaque. Cell cultures were derived from these specimens. Cultured cells
were characterized using immunofluorescence staining and immuna-surbent di
gital imaging. The cell culture supernatants were analyzed using an enzyme-
linked immunosorbent assay for the production of basic FGF. Foreskin tissue
from men without Peyronie's disease was used as control cells.
Results: Five independent cell lines were established from plaque tissue an
d 4 independent cell lines were established from normal tunica from the sam
e subjects. Intracellular antigen expression was consistent with the cells
being myofibroblasts. Production of basic FGF by the plaque derived myofibr
oblasts was significantly greater compared to production by normal tunical
myofibroblasts and foreskin fibroblasts.
Conclusions: These data demonstrate the successful establishment of cell li
nes from plaque tissue and normal tunica from men with Peyronie's disease.
The findings indicate a potential role for basic FGF over expression in the
tunical fibrosis that occurs in this condition. This information may allow
a better understanding of the basic mechanisms involved in the development
of this disease. Furthermore, it may permit the elaboration of therapeutic
strategies to prevent or reduce tunical scarring and plaque formation.